Compass R$2.8 billion IPO
We advised Compass on its IPO
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
HawkEye 360 $478.4 million IPO
We advised the underwriters on the IPO
CH4 Natural Solutions $200 million SPAC IPO
We advised the underwriters on the IPO
West Enclave Merger $100 million SPAC IPO
We advised the sole bookrunning manager in connection with the IPO
General Catalyst Global Resilience Merger $402.5 million SPAC IPO
We advised the underwriters on the IPO
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
Sunmi Technology HK$908.7 million IPO
We advised Sunmi Technology on its IPO and HKEX listing
Shanghai Xizhi Technology HK$2.5 billion IPO
We advised Shanghai Xizhi Technology on its IPO and HKEX listing
Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing
JATT II Acquisition $60 million SPAC IPO
We advised the sole bookrunning manager in connection with the IPO